Osman Kose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Osman Kose has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Sacit Nuri Görgel
Izmir Katip Celebi University
8 shared publications - Yigit Akin
Izmir Katip Celebi University
7 shared publications - Serkan Özcan
Izmir Katip Celebi University
6 shared publications - Enis Mert Yorulmaz
Izmir Katip Celebi University
5 shared publications - Yüksel Yılmaz
Department of Urology, Izmir Katip Celebi University, Izmir, Turkey
3 shared publications - Ahmet Selçuk Dindar2 shared publications
Latest Publications
- 29 September 2025
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 22 (3) , 582-587
Optimising Imaging Strategies in Suspected Urolithiasis: Effects on Diagnostic and Therapeutic Timelines
Background: Prompt imaging is essential in the diagnosis and management of urinary stone disease. While international guidelines recommend ultrasonography (US) as the first-line modality due to its safety and accessibility, delays in imaging and treatment are common in overcrowded healthcare systems. This study aimed to compare the clinical timelines and outcomes of patients undergoing initial US versus direct non-contrast computed tomography (NCCT). Materials and Methods: This retrospective study included 120 adult patients who presented to the urology department of a tertiary care hospital in Türkiye with suspected urinary stone disease. Patients were categorised based on their initial imaging modality. Time intervals from admission to imaging and from admission to definitive treatment were recorded. Treatment rates and return visits were also evaluated. Logistic regression and receiver operating characteristic (ROC) analyses were performed to identify predictors of treatment. Results: The median time to initial imaging and to definitive treatment was significantly shorter in patients who underwent direct NCCT compared to those who underwent initial US (4 vs. 10 days and 15 vs. 33.5 days, respectively; p < 0.001 for both). Multivariate analysis showed that longer imaging delays were independently associated with reduced odds of receiving treatment (OR: 0.859; 95% CI: 0.770–0.958; p = 0.006). ROC analysis demonstrated moderate predictive performance (AUC = 0.658). Conclusions: In resource-limited, high-volume settings, US may lead to diagnostic and therapeutic delays despite guideline recommendations. Direct low-dose NCCT may offer a more efficient alterna-tive without significantly increasing radiation exposure or cost. Imaging strategies should be tailored to local healthcare realities to ensure timely management of stone disease.
- 29 September 2025
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 22 (3) , 582-587
Optimising Imaging Strategies in Suspected Urolithiasis: Effects on Diagnostic and Therapeutic Timelines
Background: Prompt imaging is essential in the diagnosis and management of urinary stone disease. While international guidelines recommend ultrasonography (US) as the first-line modality due to its safety and accessibility, delays in imaging and treatment are common in overcrowded healthcare systems. This study aimed to compare the clinical timelines and outcomes of patients undergoing initial US versus direct non-contrast computed tomography (NCCT). Materials and Methods: This retrospective study included 120 adult patients who presented to the urology department of a tertiary care hospital in Türkiye with suspected urinary stone disease. Patients were categorised based on their initial imaging modality. Time intervals from admission to imaging and from admission to definitive treatment were recorded. Treatment rates and return visits were also evaluated. Logistic regression and receiver operating characteristic (ROC) analyses were performed to identify predictors of treatment. Results: The median time to initial imaging and to definitive treatment was significantly shorter in patients who underwent direct NCCT compared to those who underwent initial US (4 vs. 10 days and 15 vs. 33.5 days, respectively; p < 0.001 for both). Multivariate analysis showed that longer imaging delays were independently associated with reduced odds of receiving treatment (OR: 0.859; 95% CI: 0.770–0.958; p = 0.006). ROC analysis demonstrated moderate predictive performance (AUC = 0.658). Conclusions: In resource-limited, high-volume settings, US may lead to diagnostic and therapeutic delays despite guideline recommendations. Direct low-dose NCCT may offer a more efficient alterna-tive without significantly increasing radiation exposure or cost. Imaging strategies should be tailored to local healthcare realities to ensure timely management of stone disease.
- Open Access
AISI, SIRI, and MLR in Predicting Surgical Outcomes After Radical Cystectomy: Revisiting Inflammatory Risk Markers
Background and Objectives: This study aimed to evaluate the predictive value of systemic inflammatory response markers—namely, the Systemic Inflammatory Response Index (SIRI), Aggregate Index of Systemic Inflammation (AISI), and Monocyte-to-Lymphocyte Ratio (MLR)—in determining the occurrence of major complications following radical cystectomy. Materials and Methods: A retrospective analysis was conducted on 200 patients who underwent open radical cystectomy with ileal conduit diversion. Demographic, clinical, and laboratory variables, including albumin, creatinine, eGFR, smoking, and ASA score, were collected. SIRI, AISI, and MLR were calculated from preoperative blood counts. Major complications and their subtypes (infectious, wound, cardiopulmonary, thrombotic, and anastomotic) were adjudicated independently. Statistical analyses included multivariable logistic regression, ROC curves, calibration (Hosmer–Lemeshow, intercept, slope, and plots), bootstrap resampling (B = 2000), linearity checks (restricted cubic splines and Box–Tidwell), incremental value metrics (ΔAUC, IDI, and NRI), and decision-curve analysis (DCA). Results: Major complications occurred in 57 patients (28.5%). SIRI values were significantly higher in patients with major complications (median 2.12 vs. 1.63, p = 0.006), whereas AISI and MLR did not differ. SIRI remained an independent predictor in multivariable analysis (OR 1.37, 95% CI 1.01–1.86, p = 0.045). An AUC of 0.624 (95% CI 0.538–0.709) with a negative predictive value of 83.3% was observed for SIRI. The baseline clinical model yielded an AUC of 0.648, and an AUC of 0.672 was obtained when SIRI was added (ΔAUC = +0.024, 95% CI −0.022–0.071, p = 0.16). Calibration was excellent (intercept = 0.07, slope = 1.08), and superior net benefit was demonstrated for the SIRI-augmented model within threshold probabilities of 0.15–0.45 in DCA. A statistically significant improvement in IDI (0.024, p = 0.024) was identified, while NRI was positive but not significant. Subtype analyses indicated that the strongest associations of SIRI were with infectious and wound complications. Conclusions: SIRI was found to be an independent predictor of major complications after open radical cystectomy. Although gains in discrimination were modest, incremental analyses demonstrated improved calibration and net clinical benefit when SIRI was incorporated into a clinical model. External validation is required before translation into clinical practice.
Open AccessAISI, SIRI, and MLR in Predicting Surgical Outcomes After Radical Cystectomy: Revisiting Inflammatory Risk Markers
Background and Objectives: This study aimed to evaluate the predictive value of systemic inflammatory response markers—namely, the Systemic Inflammatory Response Index (SIRI), Aggregate Index of Systemic Inflammation (AISI), and Monocyte-to-Lymphocyte Ratio (MLR)—in determining the occurrence of major complications following radical cystectomy. Materials and Methods: A retrospective analysis was conducted on 200 patients who underwent open radical cystectomy with ileal conduit diversion. Demographic, clinical, and laboratory variables, including albumin, creatinine, eGFR, smoking, and ASA score, were collected. SIRI, AISI, and MLR were calculated from preoperative blood counts. Major complications and their subtypes (infectious, wound, cardiopulmonary, thrombotic, and anastomotic) were adjudicated independently. Statistical analyses included multivariable logistic regression, ROC curves, calibration (Hosmer–Lemeshow, intercept, slope, and plots), bootstrap resampling (B = 2000), linearity checks (restricted cubic splines and Box–Tidwell), incremental value metrics (ΔAUC, IDI, and NRI), and decision-curve analysis (DCA). Results: Major complications occurred in 57 patients (28.5%). SIRI values were significantly higher in patients with major complications (median 2.12 vs. 1.63, p = 0.006), whereas AISI and MLR did not differ. SIRI remained an independent predictor in multivariable analysis (OR 1.37, 95% CI 1.01–1.86, p = 0.045). An AUC of 0.624 (95% CI 0.538–0.709) with a negative predictive value of 83.3% was observed for SIRI. The baseline clinical model yielded an AUC of 0.648, and an AUC of 0.672 was obtained when SIRI was added (ΔAUC = +0.024, 95% CI −0.022–0.071, p = 0.16). Calibration was excellent (intercept = 0.07, slope = 1.08), and superior net benefit was demonstrated for the SIRI-augmented model within threshold probabilities of 0.15–0.45 in DCA. A statistically significant improvement in IDI (0.024, p = 0.024) was identified, while NRI was positive but not significant. Subtype analyses indicated that the strongest associations of SIRI were with infectious and wound complications. Conclusions: SIRI was found to be an independent predictor of major complications after open radical cystectomy. Although gains in discrimination were modest, incremental analyses demonstrated improved calibration and net clinical benefit when SIRI was incorporated into a clinical model. External validation is required before translation into clinical practice.
- Open Access
- 22 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1840
Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors
Background/Objectives: Upper tract urothelial carcinoma (UTUC) is often complicated by intravesical recurrence and cancer progression following radical nephroureterectomy (RNU). Identifying reliable prognostic biomarkers remains crucial for optimizing postoperative surveillance. The goal of this study was to assess the prognostic value of the De Ritis ratio (AST/ALT) in predicting bladder recurrence and oncologic outcomes in patients with clinically localized UTUC undergoing RNU. Methods: This retrospective study analyzed 87 patients treated with RNU between 2018 and 2025. Preoperative De Ritis ratios were calculated, and an optimal cut-off value of 1.682 was determined using ROC analysis. Recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were analyzed using the Kaplan–Meier and Cox regression methods. Logistic regression was used to identify independent predictors of bladder recurrence. Results: A high De Ritis ratio was significantly associated with increased bladder recurrence and worse RFS and CSS, but not OS. Multivariate analysis confirmed that an elevated De Ritis ratio, current smoking, positive surgical margins, and synchronous bladder cancer were the independent predictors of bladder recurrence. The De Ritis ratio demonstrated strong discriminatory performance (AUC: 0.807), with good sensitivity and specificity for predicting recurrence. Conclusions: The De Ritis ratio is a simple, cost-effective preoperative biomarker that may aid in identifying UTUC patients at higher risk for intravesical recurrence and cancer-specific mortality. Incorporating this ratio into clinical decision-making could enhance risk stratification and guide tailored follow-up strategies.
- 22 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1840
Open AccessPrognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors
Background/Objectives: Upper tract urothelial carcinoma (UTUC) is often complicated by intravesical recurrence and cancer progression following radical nephroureterectomy (RNU). Identifying reliable prognostic biomarkers remains crucial for optimizing postoperative surveillance. The goal of this study was to assess the prognostic value of the De Ritis ratio (AST/ALT) in predicting bladder recurrence and oncologic outcomes in patients with clinically localized UTUC undergoing RNU. Methods: This retrospective study analyzed 87 patients treated with RNU between 2018 and 2025. Preoperative De Ritis ratios were calculated, and an optimal cut-off value of 1.682 was determined using ROC analysis. Recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were analyzed using the Kaplan–Meier and Cox regression methods. Logistic regression was used to identify independent predictors of bladder recurrence. Results: A high De Ritis ratio was significantly associated with increased bladder recurrence and worse RFS and CSS, but not OS. Multivariate analysis confirmed that an elevated De Ritis ratio, current smoking, positive surgical margins, and synchronous bladder cancer were the independent predictors of bladder recurrence. The De Ritis ratio demonstrated strong discriminatory performance (AUC: 0.807), with good sensitivity and specificity for predicting recurrence. Conclusions: The De Ritis ratio is a simple, cost-effective preoperative biomarker that may aid in identifying UTUC patients at higher risk for intravesical recurrence and cancer-specific mortality. Incorporating this ratio into clinical decision-making could enhance risk stratification and guide tailored follow-up strategies.
- 1 September 2024
- Vol. 21 (5) , 313-319
The Controlling Nutritional Status (CONUT) Score as a Predictor of Local Recurrence in Patients Underwent Partial Nephrectomy Alongside the RENAL Nephrometry Score
Purpose: This study aims to assess the utility of the CONUT (Controlling Nutritional Status) Score and R.E.N.A.L. (Renal Nephrometry Score) Score in predicting tumor recurrence in patients with kidney cancer. Additionally, we investigated which parameters contributed to these scores. Materials and Methods: In total, 115 patients who underwent partial nephrectomy between January 2015 and August 2023 at a single tertiary center were enrolled. After the exclusion criteria, data from 88 patients were analyzed. Age, gender, body mass index (BMI), comorbidities (hypertension, diabetes), smoking status, tumor characteristics, CONUT Scores, and R.E.N.A.L. scores were retrospectively recorded. Statistical analyses were performed, and significant p wasp p < 0.05. Results: The presence of diabetes and hypertension showed a statistically significant association with tumor recurrence (p p = 0.033 and p = 0.003, respectively). A high BMI significantly increased the risk of recurrence (p p < 0.05). There was a strong positive relationship between the high tumor stage and positive surgical margins with recurrence (p p < 0.001). Patients with high R.E.N.A.L. Scores and high CONUT Scores had a higher risk of recurrence (42.1% and 8.7%, respectively), and this difference was statistically significant (p p < 0.001). Conclusion: CONUT and R.E.N.A.L. scores may be used to predict tumor recurrence after partial nephrectomy. Additionally, diabetes, hypertension, high BMI, and positive surgical margin rate might affect surgical success rate for recurrences. Clinicians should consider all these parameters and coring systems to gather more successful results after partial nephrectomy.
- 1 September 2024
- Vol. 21 (5) , 313-319
The Controlling Nutritional Status (CONUT) Score as a Predictor of Local Recurrence in Patients Underwent Partial Nephrectomy Alongside the RENAL Nephrometry Score
Purpose: This study aims to assess the utility of the CONUT (Controlling Nutritional Status) Score and R.E.N.A.L. (Renal Nephrometry Score) Score in predicting tumor recurrence in patients with kidney cancer. Additionally, we investigated which parameters contributed to these scores. Materials and Methods: In total, 115 patients who underwent partial nephrectomy between January 2015 and August 2023 at a single tertiary center were enrolled. After the exclusion criteria, data from 88 patients were analyzed. Age, gender, body mass index (BMI), comorbidities (hypertension, diabetes), smoking status, tumor characteristics, CONUT Scores, and R.E.N.A.L. scores were retrospectively recorded. Statistical analyses were performed, and significant p wasp p < 0.05. Results: The presence of diabetes and hypertension showed a statistically significant association with tumor recurrence (p p = 0.033 and p = 0.003, respectively). A high BMI significantly increased the risk of recurrence (p p < 0.05). There was a strong positive relationship between the high tumor stage and positive surgical margins with recurrence (p p < 0.001). Patients with high R.E.N.A.L. Scores and high CONUT Scores had a higher risk of recurrence (42.1% and 8.7%, respectively), and this difference was statistically significant (p p < 0.001). Conclusion: CONUT and R.E.N.A.L. scores may be used to predict tumor recurrence after partial nephrectomy. Additionally, diabetes, hypertension, high BMI, and positive surgical margin rate might affect surgical success rate for recurrences. Clinicians should consider all these parameters and coring systems to gather more successful results after partial nephrectomy.
- 1 June 2023
- Published by Kare Publishing in European Archives of Medical Research
- Vol. 39 (2) , 84-88
Frequency of Incidental Prostate Adenocarcinoma Detection in Patients with Radical Cystoprostatectomy for Bladder Urothelial Cancer and Research into the Need for PSA Monitoring for Local-systemic Recurrence
- 1 June 2023
- Published by Kare Publishing in European Archives of Medical Research
- Vol. 39 (2) , 84-88
Frequency of Incidental Prostate Adenocarcinoma Detection in Patients with Radical Cystoprostatectomy for Bladder Urothelial Cancer and Research into the Need for PSA Monitoring for Local-systemic Recurrence
- 26 June 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (8) , 3219-3225
Role of exosomes in skin diseases
Background: Exosomes, as a family member of extracellular vesicles, are cell‐secreted nanoscale structures that play pivotal roles in regulating physiological and pathophysiological processes of the skin. Exosomes induce communication between cells and are responsible for transporting cellular components such as microRNAs, mRNAs, DNA, lipids, metabolites, and cell‐surface proteins. Numerous preclinical and clinical trials searched the contribution of exosomes to skin functions and disorders. Thus, exosomes are gaining increasing attention within investigational dermatology. In advance, stem‐cell‐derived exosomes were integrated into the functional cosmetics industry nominated as cell‐free regenerative medicine.Objective: This review aims to demonstrate the roles of exosomes in inflammatory skin disorders, stem cell, and tumor biology through a comprehensive evaluation of the diagnostic, prognostic, and therapeutic perspectives.Methods: A comprehensive literature search was performed using electronic online databases "PubMed" and "Google Scholar" using key words ''exosomes'', ''skin'', ''wound healing''.Conclusion: Exosomes are regarded as promising diagnostic and prognostic biomarkers for various skin diseases. Future prospects are repurposing exosomes to treat skin disorders, either as drug carriers or drugs themselves.
- 26 June 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (8) , 3219-3225
Role of exosomes in skin diseases
Background: Exosomes, as a family member of extracellular vesicles, are cell‐secreted nanoscale structures that play pivotal roles in regulating physiological and pathophysiological processes of the skin. Exosomes induce communication between cells and are responsible for transporting cellular components such as microRNAs, mRNAs, DNA, lipids, metabolites, and cell‐surface proteins. Numerous preclinical and clinical trials searched the contribution of exosomes to skin functions and disorders. Thus, exosomes are gaining increasing attention within investigational dermatology. In advance, stem‐cell‐derived exosomes were integrated into the functional cosmetics industry nominated as cell‐free regenerative medicine.Objective: This review aims to demonstrate the roles of exosomes in inflammatory skin disorders, stem cell, and tumor biology through a comprehensive evaluation of the diagnostic, prognostic, and therapeutic perspectives.Methods: A comprehensive literature search was performed using electronic online databases "PubMed" and "Google Scholar" using key words ''exosomes'', ''skin'', ''wound healing''.Conclusion: Exosomes are regarded as promising diagnostic and prognostic biomarkers for various skin diseases. Future prospects are repurposing exosomes to treat skin disorders, either as drug carriers or drugs themselves.
- 15 January 2022
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (3) , 533-540
Investigation of the causes of BCG refractory in patients treated with intracavitary BCG as secondary treatment in superficial bladder tumors with transurethral resection
Background Non-muscle invasive bladder cancers (NMIBC) tend to recur and progress over time. Bacillus Calmette–Guerin (BCG) is an effective therapy for the treatment of NMIBC in that it reduces both recurrence and progression rates. The present study investigates the causes of BCG failure, with emphasis on those attributable to application errors by the practitioner and/or patient. Methods The demographic and histopathological characteristics of 115 patients who underwent TUR-B for primary bladder tumors and who underwent intracavitary BCG in the postoperative period in the Urology Clinic of the İzmir Katip Çelebi University Atatürk Training and Research Hospital between January 2014 and January 2019, were analyzed retrospectively. BCG-refractory patients were compared with non-BCG refractory patients after BCG administration. Results The extent of the tumor, and the involvement of the tumor in the bladder trigone and/or the bladder neck were found to increase significantly the likelihood of BCG refractory. When the micturition times of both groups were compared after instillation, the differences between the groups were found to be statistically significant. In the BCG-refractory patient group, the micturition time after instillation was shorter due to the tumor involvement in the trigone/bladder neck. Conclusion Some modifiable factors originating from the patient and the tumoral characteristics were found to have an effect on BCG failure. It was further determined that the time until micturition after BCG administration is an important parameter to be considered in the prevention of application deficiencies. We believe these factors should be subjected to careful consideration during patient selection and follow-up.
- 15 January 2022
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (3) , 533-540
Investigation of the causes of BCG refractory in patients treated with intracavitary BCG as secondary treatment in superficial bladder tumors with transurethral resection
Background Non-muscle invasive bladder cancers (NMIBC) tend to recur and progress over time. Bacillus Calmette–Guerin (BCG) is an effective therapy for the treatment of NMIBC in that it reduces both recurrence and progression rates. The present study investigates the causes of BCG failure, with emphasis on those attributable to application errors by the practitioner and/or patient. Methods The demographic and histopathological characteristics of 115 patients who underwent TUR-B for primary bladder tumors and who underwent intracavitary BCG in the postoperative period in the Urology Clinic of the İzmir Katip Çelebi University Atatürk Training and Research Hospital between January 2014 and January 2019, were analyzed retrospectively. BCG-refractory patients were compared with non-BCG refractory patients after BCG administration. Results The extent of the tumor, and the involvement of the tumor in the bladder trigone and/or the bladder neck were found to increase significantly the likelihood of BCG refractory. When the micturition times of both groups were compared after instillation, the differences between the groups were found to be statistically significant. In the BCG-refractory patient group, the micturition time after instillation was shorter due to the tumor involvement in the trigone/bladder neck. Conclusion Some modifiable factors originating from the patient and the tumoral characteristics were found to have an effect on BCG failure. It was further determined that the time until micturition after BCG administration is an important parameter to be considered in the prevention of application deficiencies. We believe these factors should be subjected to careful consideration during patient selection and follow-up.
- 27 June 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (2) , 491-496
Carbon dioxide ablative laser treatment of acquired junctional melanocytic nevi
Background: Junctional melanocytic nevi are common. Furthermore, surgical treatment of these nevi can be challenging due to scar formation.Aims: The study aims to detect the efficacy and safety of the CO2fractional laser for treating acquired junctional melanocytic nevi and usefulness of dermatoscopy for the monitoring of the nevus.Methods: We conducted a retrospective review of 618 patients with 1545 facial junctional melanocytic nevi. CO2fractional laser was applied to 2‐month intervals until complete clearance was reached. The effect of the therapy was monitored by clinical and dermatoscopy. The Global Assessment Scale (GAS) scores were used to assess the results.Results: 1320 nevi (85%) were treated in just one session. In addition, 120 (8%) and 75 (5%) required second and third sessions, respectively. Only thirty nevi (2%) need more than three sessions. Consequently, at the end of one‐year follow‐up, patients' (97%) and physicians' (95%) GAS scores were rated as excellent and good, respectively. Moreover, hyper/hypopigmentation, fibrosis, dimples, erythema, and scars were observed as side effects at the 1‐year follow‐up.Conclusions: CO2laser is effective in completely removing small acquired junctional melanocytic nevus. Furthermore, dermatoscopy appears to be helpful for monitorization of the nevi in the follow‐up period.
- 27 June 2020
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (2) , 491-496
Carbon dioxide ablative laser treatment of acquired junctional melanocytic nevi
Background: Junctional melanocytic nevi are common. Furthermore, surgical treatment of these nevi can be challenging due to scar formation.Aims: The study aims to detect the efficacy and safety of the CO2fractional laser for treating acquired junctional melanocytic nevi and usefulness of dermatoscopy for the monitoring of the nevus.Methods: We conducted a retrospective review of 618 patients with 1545 facial junctional melanocytic nevi. CO2fractional laser was applied to 2‐month intervals until complete clearance was reached. The effect of the therapy was monitored by clinical and dermatoscopy. The Global Assessment Scale (GAS) scores were used to assess the results.Results: 1320 nevi (85%) were treated in just one session. In addition, 120 (8%) and 75 (5%) required second and third sessions, respectively. Only thirty nevi (2%) need more than three sessions. Consequently, at the end of one‐year follow‐up, patients' (97%) and physicians' (95%) GAS scores were rated as excellent and good, respectively. Moreover, hyper/hypopigmentation, fibrosis, dimples, erythema, and scars were observed as side effects at the 1‐year follow‐up.Conclusions: CO2laser is effective in completely removing small acquired junctional melanocytic nevus. Furthermore, dermatoscopy appears to be helpful for monitorization of the nevi in the follow‐up period.
- 1 January 2019
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 13 (3) , 117-122
The efficacy of interfollicular epidermal stem cells versus bone marrow-derived mesenchymal stem cells in cutaneous wound healing in diabetic rats
Objective: Many sources of stem cells, such as bone marrow stem cells, embriyonic stem cells, adipose-derived stem cells, epidermal stem cells were used extensively for diabetic wound healing. This study investigated whether interfollicular epidermal stem cell versus bone marrow-derived mesenchymal stem cell effectiveness in the enhancement of diabetic wound healing. Methods: The streptozotocin-induced Spraque-Dowley rats with 5 mm punch biopsy were used. Rats were divided into three groups: group I diabetic controls receiving no stem cells; group II, rats receiving bone marrow-derived mesenchymal stem cells; group III, rats receiving interfollicular epidermal stem cells. Wound healing was assessed clinically that regarding healing time and wound size. Results: Clinical results showed that wound size was significantly reduced in mesenchymal and interfollicular epidermal stem cell-treated groups as compared with controls. Complete wound-healing times were 19.4±2.85 days in bone marrow-derived mesenchymal stem cells group versus 20.3±3.45 days in interfollicular epidermal stem cells group and 24.7±4.17 in the control group. In the measurement of the wound area, there were no significant differences between the bone marrow-derived mesenchymal stem cells group (P=0.115) and interfollicular epidermal stem cells group (P=0.085). Conclusions: Interfollicular epidermal stem cells were found as effective as bone marrow-derived mesenchymal cells in the treatment of the diabetic wound.
- 1 January 2019
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 13 (3) , 117-122
The efficacy of interfollicular epidermal stem cells versus bone marrow-derived mesenchymal stem cells in cutaneous wound healing in diabetic rats
Objective: Many sources of stem cells, such as bone marrow stem cells, embriyonic stem cells, adipose-derived stem cells, epidermal stem cells were used extensively for diabetic wound healing. This study investigated whether interfollicular epidermal stem cell versus bone marrow-derived mesenchymal stem cell effectiveness in the enhancement of diabetic wound healing. Methods: The streptozotocin-induced Spraque-Dowley rats with 5 mm punch biopsy were used. Rats were divided into three groups: group I diabetic controls receiving no stem cells; group II, rats receiving bone marrow-derived mesenchymal stem cells; group III, rats receiving interfollicular epidermal stem cells. Wound healing was assessed clinically that regarding healing time and wound size. Results: Clinical results showed that wound size was significantly reduced in mesenchymal and interfollicular epidermal stem cell-treated groups as compared with controls. Complete wound-healing times were 19.4±2.85 days in bone marrow-derived mesenchymal stem cells group versus 20.3±3.45 days in interfollicular epidermal stem cells group and 24.7±4.17 in the control group. In the measurement of the wound area, there were no significant differences between the bone marrow-derived mesenchymal stem cells group (P=0.115) and interfollicular epidermal stem cells group (P=0.085). Conclusions: Interfollicular epidermal stem cells were found as effective as bone marrow-derived mesenchymal cells in the treatment of the diabetic wound.
- 19 November 2018
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 30 (5) , 498-502
Efficacy of the carbon dioxide fractional laser in the treatment of compound and dermal facial nevi using with dermatoscopic follow-up
Background: Surgical excision for nevi can produce scar formation. Treatment of compound and dermal nevi, especially on the face, can be challenging. Objectives: The study objectives included an assessment of the efficacy and safety of the CO2 fractional laser for removing compound and dermal nevi and usefulness of dermoscopy for the monitoring of the nevus. Methods: We performed a retrospective review of 330 patients with 684 facial nevi. CO2 fractional laser was performed at 2-month intervals until complete clearance occurred. The Global Assessment Scale (GAS) scores were used to assess the overall results. Results: Five-hundred fifty-four nevi (81%) were successfully treated in one session. Eighty-nine (13%) and 34 (5%) required second and third sessions, respectively. Only seven (1%) required >3sessions. At the end of one year, patients’ (87%) and physicians’ (85%) GAS scores were rated as excellent and good, respectively. At the one year follow-up, fibrosis in 20 patients (3%), recurrences in 15 (2%), dimples in 12 (2%), scars in 12 (2%), hyperpigmentation in 8 (1.5%), and hypopigmentation in 6 (1%) were observed as side effects. Conclusions: CO2 laser produced excellent cosmetic results, led to high patient satisfaction, and could be easily performed. Dermoscopy can be helpful for long-term follow-up.
- 19 November 2018
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 30 (5) , 498-502
Efficacy of the carbon dioxide fractional laser in the treatment of compound and dermal facial nevi using with dermatoscopic follow-up
Background: Surgical excision for nevi can produce scar formation. Treatment of compound and dermal nevi, especially on the face, can be challenging. Objectives: The study objectives included an assessment of the efficacy and safety of the CO2 fractional laser for removing compound and dermal nevi and usefulness of dermoscopy for the monitoring of the nevus. Methods: We performed a retrospective review of 330 patients with 684 facial nevi. CO2 fractional laser was performed at 2-month intervals until complete clearance occurred. The Global Assessment Scale (GAS) scores were used to assess the overall results. Results: Five-hundred fifty-four nevi (81%) were successfully treated in one session. Eighty-nine (13%) and 34 (5%) required second and third sessions, respectively. Only seven (1%) required >3sessions. At the end of one year, patients’ (87%) and physicians’ (85%) GAS scores were rated as excellent and good, respectively. At the one year follow-up, fibrosis in 20 patients (3%), recurrences in 15 (2%), dimples in 12 (2%), scars in 12 (2%), hyperpigmentation in 8 (1.5%), and hypopigmentation in 6 (1%) were observed as side effects. Conclusions: CO2 laser produced excellent cosmetic results, led to high patient satisfaction, and could be easily performed. Dermoscopy can be helpful for long-term follow-up.